Patient Square Capital’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Patient Square Capital's ONC Position: Q3 2026 in Review
Patient Square Capital reduced its BeOne Medicines (ONC) stake by 63% in Q3 2026, selling an estimated $19.3M and leaving 33,500 shares worth $12.3M. The position accounts for 1.96% of the portfolio, ranked #13.
Patient Square Capital first reported a position in ONC in Q4 2025 and has held it in 4 quarters since. The position peaked at $25.7M in Q2 2026. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.
- Patient Square Capital held 33,500 shares of BeOne Medicines worth $12.3M as of Q3 2026.
- Patient Square Capital sold 56,520 BeOne Medicines shares in Q3 2026, an estimated $19.3M.
- BeOne Medicines made up 1.96% of Patient Square Capital's portfolio in Q3 2026, its #13 holding.
- Patient Square Capital first reported a position in BeOne Medicines in Q4 2025 and has held it in 4 quarters since.
- Patient Square Capital's BeOne Medicines position peaked at $25.7M in Q2 2026.
- 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.
Based on Patient Square Capital's 13F filing for Q3 2026, filed 10 Nov 2026.